JP2009504576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504576A5 JP2009504576A5 JP2008525352A JP2008525352A JP2009504576A5 JP 2009504576 A5 JP2009504576 A5 JP 2009504576A5 JP 2008525352 A JP2008525352 A JP 2008525352A JP 2008525352 A JP2008525352 A JP 2008525352A JP 2009504576 A5 JP2009504576 A5 JP 2009504576A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glutamine
- source
- use according
- glutamine source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 16
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 10
- 108010016626 Dipeptides Proteins 0.000 claims 4
- 229930182816 L-glutamine Natural products 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 206010060932 Postoperative adhesion Diseases 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 238000007912 intraperitoneal administration Methods 0.000 claims 3
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical group C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims 2
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 2
- 108010044940 alanylglutamine Proteins 0.000 claims 2
- 229960002648 alanylglutamine Drugs 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000003200 peritoneal cavity Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70717305P | 2005-08-11 | 2005-08-11 | |
| US60/707,173 | 2005-08-11 | ||
| PCT/CA2006/001319 WO2007016791A1 (en) | 2005-08-11 | 2006-08-11 | Reducing post-operative adhesion formation with intraperitoneal glutamine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009504576A JP2009504576A (ja) | 2009-02-05 |
| JP2009504576A5 true JP2009504576A5 (https=) | 2009-09-24 |
| JP5194207B2 JP5194207B2 (ja) | 2013-05-08 |
Family
ID=37727066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525352A Active JP5194207B2 (ja) | 2005-08-11 | 2006-08-11 | 腹腔内グルタミンによる術後癒着形成の減少 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20100260819A1 (https=) |
| EP (1) | EP1940439B1 (https=) |
| JP (1) | JP5194207B2 (https=) |
| AT (1) | ATE485829T1 (https=) |
| AU (1) | AU2006279218B2 (https=) |
| CA (1) | CA2618600C (https=) |
| CY (1) | CY1112051T1 (https=) |
| DE (1) | DE602006017864D1 (https=) |
| DK (1) | DK1940439T3 (https=) |
| ES (1) | ES2355159T3 (https=) |
| PL (1) | PL1940439T3 (https=) |
| PT (1) | PT1940439E (https=) |
| SI (1) | SI1940439T1 (https=) |
| WO (1) | WO2007016791A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1940439B1 (en) | 2005-08-11 | 2010-10-27 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
| CA2578647A1 (en) * | 2007-02-15 | 2008-08-15 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
| WO2008106702A1 (en) | 2007-03-02 | 2008-09-12 | Zytoprotec Gmbh | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| US20100082113A1 (en) * | 2008-04-29 | 2010-04-01 | Peter Gingras | Tissue repair implant |
| RU2578426C2 (ru) * | 2010-06-28 | 2016-03-27 | Эдитерапьютикс, Инк. | Лечение келоидов |
| US20150209481A1 (en) | 2012-08-16 | 2015-07-30 | Nipro Corporation | Antiadhesive Material |
| JP7160683B2 (ja) | 2016-04-29 | 2022-10-25 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 術後癒着の予防及び治療のための方法及び組成物 |
| EP3471791B1 (en) | 2016-06-15 | 2020-08-05 | Tubitak | Multifunctional hernia patch |
| US10500318B1 (en) * | 2018-07-03 | 2019-12-10 | Temple Therapeutics BV | Dosing regimens for treating hypoxia-associated tissue damage |
| WO2022234489A1 (en) * | 2021-05-07 | 2022-11-10 | Temple Therapeutics BV | Methods of treating fibrosis and hypoxia-associated damage to peripheral nerves |
| WO2025163204A1 (en) | 2024-02-01 | 2025-08-07 | Temple Therapeutics BV | Glutamine source for use in methods and compositions for reducing or preventing synovial joint adhesions or fibrosis |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2026881A1 (en) * | 1989-02-08 | 1990-08-09 | Masao Tanihara | Peptide and adsorbent thereof immobilized on carrier |
| US5248697A (en) | 1990-09-20 | 1993-09-28 | Brigham And Women's Hospital | Enhancement of glutathione levels with glutamine |
| CA2114290C (en) * | 1993-01-27 | 2006-01-10 | Nagabushanam Totakura | Post-surgical anti-adhesion device |
| US5425740A (en) * | 1994-05-17 | 1995-06-20 | Hutchinson, Jr.; William B. | Endoscopic hernia repair clip and method |
| US6965014B1 (en) * | 1996-01-16 | 2005-11-15 | Baxter International Inc. | Fibrin material and method for producing and using the same |
| US6280745B1 (en) * | 1997-12-23 | 2001-08-28 | Alliance Pharmaceutical Corp. | Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| US5693671A (en) * | 1996-05-01 | 1997-12-02 | Harbor-Ucla Research And Education Institute | L-glutamine therapy for sickle cell diseases and thalassemia |
| GB9609993D0 (en) | 1996-05-14 | 1996-07-17 | Norbrook Lab Ltd | Oral rehydration product |
| US6797729B1 (en) * | 1996-06-28 | 2004-09-28 | Baxter International Inc. | Therapeutic glutamine and N-actyl-cysteine composition |
| US6063061A (en) * | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| WO1999009982A1 (en) * | 1997-08-25 | 1999-03-04 | Harold Brem | Prevention of adhesions and excessive scar formation using angiogenesis inhibitors |
| AU4572899A (en) * | 1998-06-16 | 2000-01-05 | Biogen, Inc. | Variant type ii tgf-beta receptor fusion proteins and methods |
| JP2002521423A (ja) | 1998-07-31 | 2002-07-16 | コリア インスティチュート オブ サイエンス アンド テクノロージ | 遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子 |
| US6613070B2 (en) * | 1998-08-04 | 2003-09-02 | Baxter International Inc. | System and method for sealing vascular penetrations with hemostatic gels |
| US20030007951A1 (en) | 2000-08-23 | 2003-01-09 | Richard Franklin | Treatment of trauma |
| WO2004032653A1 (en) | 2002-10-08 | 2004-04-22 | Abbott Laboratories | Methods and compositions for providing glutamine |
| WO2005030243A1 (en) | 2003-09-26 | 2005-04-07 | Bristol Myers Squibb Company | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| EP1940439B1 (en) | 2005-08-11 | 2010-10-27 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
-
2006
- 2006-08-11 EP EP20060775098 patent/EP1940439B1/en active Active
- 2006-08-11 PL PL06775098T patent/PL1940439T3/pl unknown
- 2006-08-11 JP JP2008525352A patent/JP5194207B2/ja active Active
- 2006-08-11 AU AU2006279218A patent/AU2006279218B2/en active Active
- 2006-08-11 SI SI200630887T patent/SI1940439T1/sl unknown
- 2006-08-11 US US12/063,423 patent/US20100260819A1/en not_active Abandoned
- 2006-08-11 CA CA2618600A patent/CA2618600C/en active Active
- 2006-08-11 DE DE200660017864 patent/DE602006017864D1/de active Active
- 2006-08-11 AT AT06775098T patent/ATE485829T1/de active
- 2006-08-11 PT PT06775098T patent/PT1940439E/pt unknown
- 2006-08-11 DK DK06775098T patent/DK1940439T3/da active
- 2006-08-11 WO PCT/CA2006/001319 patent/WO2007016791A1/en not_active Ceased
- 2006-08-11 ES ES06775098T patent/ES2355159T3/es active Active
-
2011
- 2011-01-04 CY CY20111100013T patent/CY1112051T1/el unknown
-
2013
- 2013-02-27 US US13/779,362 patent/US9011883B2/en active Active
-
2015
- 2015-03-17 US US14/660,382 patent/US20150250928A1/en not_active Abandoned
-
2017
- 2017-04-05 US US15/480,148 patent/US20170203013A1/en not_active Abandoned
-
2018
- 2018-11-05 US US16/180,637 patent/US10799622B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7627214B2 (ja) | 発泡体組成物、発泡体マトリックスおよび方法 | |
| JP6568519B2 (ja) | 医療用被覆器具 | |
| US20070286892A1 (en) | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals | |
| JP2010520186A5 (https=) | ||
| JP2009504576A5 (https=) | ||
| CN102006893A (zh) | 粘膜组织敷料及其使用方法 | |
| JP2013100347A5 (https=) | ||
| JP2009269923A5 (https=) | ||
| JP2005527535A5 (https=) | ||
| IL203747A (en) | Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it | |
| IL174562A0 (en) | Oros push-stick for controlled delivery of active agent | |
| JP2013121983A5 (https=) | ||
| WO2010039641A3 (en) | Long term drug delivery devices with polyurethane-based polymers and their manufacture | |
| PL2062602T3 (pl) | Nowy, nietoksyczny i biodegradowalny klej biologiczny przeznaczony do stosowania w chirurgii jamy brzusznej | |
| WO2005043971A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| JP2019534288A5 (https=) | ||
| JP2005524648A5 (https=) | ||
| WO2007098479A3 (en) | Localized insulin delivery for bone healing | |
| WO2004037207A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| JP2012508256A5 (https=) | ||
| JP2010520184A5 (https=) | ||
| EP2392322A3 (en) | Dosing regimes for trans-clomiphene | |
| IL194500A (en) | A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above | |
| MX2009005503A (es) | Uso de l-carnitina para la preparacion de un medicamento en forma de gotas oculares para el tratamiento de enfermedades de la cornea. | |
| JP2005511708A5 (https=) |